Sanara MedTech

Fort Worth, United States Founded: 1982 • Age: 44 yrs Listed
Developer of therapeutics for infectious disease

About Sanara MedTech

Sanara MedTech is a publicly listed company based in Fort Worth (United States) founded in 1982. The company has 141 employees. Sanara MedTech has completed 2 acquisitions, including Precision Healing and Scendia Biologics. Its website sanaramedtech.com draws about 13 thousand monthly visits. Sanara MedTech offers products and services including CellerateRX® Surgical Powder, FORTIFY TRG® Tissue Repair Graft, FORTIFY FLOWABLE® Extracellular Matrix, TEXAGEN® Amniotic Membrane Allograft, and BIAKŌS® Antimicrobial Wound Gel. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Diversified. Its legal entity is Sanara MedTech Inc. Similar companies include Vir Biotechnology, Vaxcyte and Cidara Therapeutics; 3 of its 3 listed similar companies have raised funding.

Company details

Developer of therapeutics for infectious disease. The platform has developed wound care products that include BIAKŌS for antimicrobial skin and wound cleaning and PULSAR II is the wound irrigation system. The platform also developed surgical products that include CellerateRX is surgical powder.

  • Headquarters Fort Worth, United States
  • Employees 141
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website sanaramedtech.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Sanara Medtech Inc.
Key Metrics
  • Annual Revenue
    $103.12 M (USD)
    18.97
    as on Dec 31, 2025
  • Net Profit
    -$37.56 M (USD)
    -288.66
    as on Dec 31, 2025
  • EBITDA
    $11.81 M (USD)
    180.11
    as on Dec 31, 2025
  • Employee Count
    141
  • Investments & Acquisitions

Products & Services of Sanara MedTech

Sanara MedTech offers a comprehensive portfolio of products and services, including CellerateRX® Surgical Powder, FORTIFY TRG® Tissue Repair Graft, FORTIFY FLOWABLE® Extracellular Matrix, TEXAGEN® Amniotic Membrane Allograft, and BIAKŌS® Antimicrobial Wound Gel.

CellerateRX® Surgical Powder
Wound Management

Aids in natural healing of surgical wounds using hydrolyzed collagen.

FORTIFY TRG® Tissue Repair Graft
Tissue Repair

Reinforces soft tissue through porcine submucosa implantation.

FORTIFY FLOWABLE® Extracellular Matrix
Surgical Support

Provides micronized matrix for managing surgical wounds effectively.

TEXAGEN® Amniotic Membrane Allograft
Wound Covering

Serves as a barrier for various soft tissue applications.

BIAKŌS® Antimicrobial Wound Gel
Infection Control

Disrupts biofilms to aid in wound healing and microbe elimination.

Apps and channels of Sanara MedTech

its YouTube channel Sanara MedTech has 137 subscribers and 30 videos.

Sanara MedTech
YouTube 137 subscribers 30 videos Science & Technology
Open channel

Videos from Sanara MedTech

The most watched videos on Sanara MedTech's YouTube channel, Sanara MedTech (137 subscribers). Click a video to play it here.

TEXAGEN® Amniotic Membrane Allograft Application Video
23.1K views
CellerateRX® Surgical Powder Application Video- 37 Year Old Female
1.4K views
HYCOL® HYDROLYZED COLLAGEN Patient Application Video
1.4K views
HYCOL™ HYDROLYZED COLLAGEN Gel Application Video
1.2K views

More on Sanara MedTech.

People of Sanara MedTech

49 people are tracked at Sanara MedTech (23 in leadership, 26 in team); the tracked headcount is 141.

NameRoleGroup
Marina Tena
Managing DirectorLeadership
Bill Fitzgerald
Chief Compliance OfficerLeadership
Rebecca E. Mcmahon
President, Sanara Research And DevelopmentLeadership
Seth Yon
President, CommercialLeadership
Karen Igo
Director Of Financial ReportingLeadership
Carla Day
Director, Customer And Sales ServicesLeadership
Paul Harris
Marketing DirectorLeadership
Rachel Walton
Vice President Market DevelopmentLeadership
Jay Speelhoffer
Senior Director, Business OperationsLeadership
Elizabeth McTaggart
Human Resources DirectorLeadership
Craig C Perkins
Senior Director National Accounts And Market AccessLeadership
Kevin Luebke
Director Of Manufacturing And CommercializationLeadership
Rob Eisterhold
Vice President Of SalesLeadership
Tyler Palmer
Chief Corporate Development & Strategy OfficerLeadership
Robert Bearden
Vice President, Medical Sciences And TechnologyLeadership
Nick Martin
Marketing DirectorLeadership
Tricia Matteson
Vice President, MarketingLeadership
Prodromos Ververeli
Vice President, Medical AffairsLeadership
Prody Ververeli
Vice President, Medical AffairsLeadership
Patricia Morley Matteson
Vice President, MarketingLeadership

29 more people are available in the full profile.

Premium access

Complete people profiles for Sanara MedTech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Sanara MedTech

Sanara MedTech is a publicly listed company on the NASDAQ with ticker symbol SMTI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date15 May 2018
  • Listed onNASDAQ: SMTI
  • Listed entitySanara MedTech Inc.
  • Exchange sectorHealth technology
  • ISINUS79957L1008
  • Share price$35.14 (-0.03% on the day) · 2026-10-13
  • Market capitalisation$322.9M
  • EPS (diluted, trailing year)$-3.71
  • Volume (last session)124,872

Financials of Sanara MedTech

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$103.1M-$37.6M$11.8M
2024$86.7M-$9.7M$4.2M
2023$65.0M-$4.3M-$4.0M
2022$45.8M-$7.9M-$9.6M
2021$24.1M-$7.9M-$6.6M
Premium access

Detailed financial statements for Sanara MedTech

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sanara MedTech

Sanara MedTech has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Precision Healing and Scendia Biologics.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Bone minerals and traditional grafts are manufactured by Scendia Biologics.
scendiabiologics.comOrlando, United States2016Jul 2022$7.4M
Therapeutic massage services are provided in Portland, United States.
precisionhealingclinic.comPortland, United States2011Apr 2022••••
Premium access

Complete acquisition details for Sanara MedTech

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Sanara MedTech

4 dated milestones of Sanara MedTech across 40 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sanara MedTech is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Precision Healing.
  4. Acquisition Acquires Scendia Biologics.

Similar companies to Sanara MedTech

Sanara MedTech has 3 listed similar companies in our database, 3 of them funded. They include Vir Biotechnology, Vaxcyte and Cidara Therapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
vir.bio2017San Francisco, United States$216M417
Developer of therapeutics for the treatment of infectious diseases
vaxcyte.com2013Foster, United States$347M254
Vaccines for infectious diseases are developed using cell-free protein synthesis.
cidara.com2013San Diego, United States$78.35M90
Novel anti-infectives for bacterial and fungal infections are developed.
Premium access

Detailed similar companies of Sanara MedTech

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Sanara MedTech

The website of Sanara MedTech (sanaramedtech.com) receives about 13.4K visits a month.

  • Monthly visits
    13.4K

    ▼ 31% vs previous month

Similar websites

Websites whose visitors overlap most with Sanara MedTech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
supplypt.com
100%
#849,332View details
delasco.com
delasco.com
93%
#1,351,389–
mycoldtherapy.com
86%
#694,371View details
sebamedindia.com
80%
46.9K#665,109View details
carewell.com
80%
611K#76,793View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 17 similar websites and full traffic analytics for Sanara MedTech

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 17 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Wound Care

3 companies that operate in the same segment as Sanara MedTech (Wound Care) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanotech-based wound care products are developed and provided.
2010Madison, Wisconsin, United StatesUSD 22.7 M35
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
1985Marietta, Georgia, United StatesUSD 418.63 M837
Developer of hemostatic products for wound care
2010New York, New York, United StatesUSD 113.35 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sanara Medtech

Premium access

Complete news archive for Sanara MedTech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanara MedTech

Sanara MedTech was founded in 1982.

Sanara MedTech is headquartered in Fort Worth, United States. It is registered at Fort Worth, Texas, United States.

Sanara MedTech has 141 employees.

Annual revenue of Sanara MedTech is $103.12M as on Dec 31, 2025.

Developer of therapeutics for infectious disease. The platform has developed wound care products that include BIAKŌS for antimicrobial skin and wound cleaning and PULSAR II is the wound irrigation system. The platform also developed surgical products that include CellerateRX is surgical powder.

Sanara MedTech's top competitors include Vaxcyte, Vir Biotechnology and Cidara Therapeutics.

Sanara MedTech offers CellerateRX® Surgical Powder, FORTIFY TRG® Tissue Repair Graft, FORTIFY FLOWABLE® Extracellular Matrix, TEXAGEN® Amniotic Membrane Allograft, and BIAKŌS® Antimicrobial Wound Gel.

Yes, Sanara MedTech is publicly traded on NASDAQ under the ticker symbol SMTI.

Sanara MedTech has made 2 acquisitions, including Precision Healing, and Scendia Biologics.

Sanara MedTech operates through Sanara Medtech Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available